NORCROSS, Ga., Jan. 19 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Michael Pred has joined the Company as Vice President, Operations, responsible for overseeing all U.S. manufacturing operations.

Mr. Pred has more than 15 years pharmaceutical manufacturing experience with both Pfizer and Merck & Co. Most recently, he led all manufacturing in a multi-plant operation for vaccine production for Pfizer Animal Health. Prior to joining Pfizer, Mr. Pred held various manufacturing leadership roles at Merck. He spent seven years in the U.S. Navy, as a nuclear-trained submarine officer. Mr. Pred holds a B.S. in chemical engineering from the University of Wisconsin.

"With his strong working knowledge of manufacturing best practices and his proven commitment to excellence, Mike will help Immucor maintain our strong commitment to product quality and quality compliance while enhancing manufacturing efficiency," stated Dr. Gioacchino De Chirico.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com .

SOURCE Immucor, Inc.